CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-12 | Hillsberg Sanford Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2015-06-08 | Henderson Molly Chief Financial Officer | Grant or award · Stock Option | +200,000 | 200,000 | ||
| 2015-05-06 | Hillsberg Sanford Director | Sale | −50,000 | $10.00 | $500K | 219,000 |
| 2015-05-01 | Ayer Capital Management, LP 10% owner | Sale | −2,780,682 | $9.62 | $26.8M | 2,823,333 |
| 2015-02-28 | HAWKINS ELMA President and CEO | Exercise or conversion | +40,000 | 200,555 | ||
| 2015-02-28 | HAWKINS ELMA President and CEO | Shares withheld for taxes | −23,988 | $8.98 | $215K | 176,567 |
| 2015-02-28 | HAWKINS ELMA President and CEO | Exercise or conversion · Restricted Stock | −40,000 | 160,000 | ||
| 2015-02-16 | Maynard Ryan D Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2015-01-28 | Hillsberg Sanford Director | Other disposition | −25,000 | 0 | ||
| 2015-01-28 | Hillsberg Sanford Director | Other disposition · Warrant | −25,000 | 0 | ||
| 2014-12-16 | Hillsberg Sanford Director | Grant or award | +25,000 | 25,000 | ||
| 2014-12-16 | Hillsberg Sanford Director | Grant or award · Warrant | +25,000 | 25,000 | ||
| 2014-12-05 | Radvanyi Laszlo Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +32,407 | 32,407 | ||
| 2014-12-05 | Venkatesan Jay Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2014-12-05 | MCPEAK MERRILL A Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2014-12-05 | Handelman Michael D Chief Financial Officer | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2014-12-05 | Bender James G. Vice President, Manufacturing | Grant or award · Stock Option (right to buy) | +46,666 | 46,666 | ||
| 2014-12-05 | Hillsberg Sanford Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2014-11-06 | BRISTOL INVESTMENT FUND LTD 10% owner | Sale | −100,000 | $690,000.00 | $69.0B | 3,867,863 |
| 2014-08-21 | HAWKINS ELMA President & COO | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 |
Page 28 of 31 · 605 trades